Feitelson MA - Search Results

1

Adenoviral-mediated RNA interference targeting URG11 inhibits growth of human hepatocellular carcinoma.

Fan R, Li X, Du W, Zou X, Du R, Zhao L, Luo G, Mo P, Xia L, Pan Y, Shi Y, Lian Z, Feitelson MA, Nie Y, Liu J, Fan D. Fan R, et al. Among authors: feitelson ma. Int J Cancer. 2011 Jun 15;128(12):2980-93. doi: 10.1002/ijc.25624. Epub 2010 Oct 8. Int J Cancer. 2011. PMID: 20725996

2

Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib.

Xie H, Gao L, Chai N, Song J, Wang J, Song Z, Chen C, Pan Y, Zhao L, Sun S, Wu K, Feitelson MA, Liu J, Fan D. Xie H, et al. Among authors: feitelson ma. Mol Carcinog. 2009 Jan;48(1):56-65. doi: 10.1002/mc.20455. Mol Carcinog. 2009. PMID: 18506760

3

Enhanced cell survival of Hep3B cells by the hepatitis B x antigen effector, URG11, is associated with upregulation of beta-catenin.

Lian Z, Liu J, Li L, Li X, Clayton M, Wu MC, Wang HY, Arbuthnot P, Kew M, Fan D, Feitelson MA. Lian Z, et al. Among authors: feitelson ma. Hepatology. 2006 Mar;43(3):415-24. doi: 10.1002/hep.21053. Hepatology. 2006. PMID: 16496348

4

Increased expression of ErbB-2 in liver is associated with hepatitis B x antigen and shorter survival in patients with liver cancer.

Liu J, Ahiekpor A, Li L, Li X, Arbuthnot P, Kew M, Feitelson MA. Liu J, et al. Among authors: feitelson ma. Int J Cancer. 2009 Oct 15;125(8):1894-901. doi: 10.1002/ijc.24580. Int J Cancer. 2009. PMID: 19610068 Free PMC article.

5

Cloning of differentially expressed genes in human hepatocellular carcinoma and nontumor liver.

Cao XY, Liu J, Lian ZR, Clayton M, Hu JL, Zhu MH, Fan DM, Feitelson M. Cao XY, et al. World J Gastroenterol. 2001 Aug;7(4):579-82. doi: 10.3748/wjg.v7.i4.579. World J Gastroenterol. 2001. PMID: 11819835 Free PMC article. No abstract available.

6

Downregulation of E-cadherin by hepatitis B virus X antigen in hepatocellullar carcinoma.

Liu J, Lian Z, Han S, Waye MM, Wang H, Wu MC, Wu K, Ding J, Arbuthnot P, Kew M, Fan D, Feitelson MA. Liu J, et al. Among authors: feitelson ma. Oncogene. 2006 Feb 16;25(7):1008-17. doi: 10.1038/sj.onc.1209138. Oncogene. 2006. PMID: 16247464

7

The hepatitis B x antigen effector, URG7, blocks tumour necrosis factor alpha-mediated apoptosis by activation of phosphoinositol 3-kinase and beta-catenin.

Pan J, Lian Z, Wallet S, Feitelson MA. Pan J, et al. Among authors: feitelson ma. J Gen Virol. 2007 Dec;88(Pt 12):3275-3285. doi: 10.1099/vir.0.83214-0. J Gen Virol. 2007. PMID: 18024896

8

Role of miR-148a in hepatitis B associated hepatocellular carcinoma.

Yuan K, Lian Z, Sun B, Clayton MM, Ng IO, Feitelson MA. Yuan K, et al. Among authors: feitelson ma. PLoS One. 2012;7(4):e35331. doi: 10.1371/journal.pone.0035331. Epub 2012 Apr 9. PLoS One. 2012. PMID: 22496917 Free PMC article.

9

Differentially expressed genes in hepatocellular carcinoma induced by woodchuck hepatitis B virus in mice.

Cao XY, Liu J, Lian ZR, Clayton M, Hu JL, Zhu MH, Fan DM, Feitelson M. Cao XY, et al. World J Gastroenterol. 2001 Aug;7(4):575-8. doi: 10.3748/wjg.v7.i4.575. World J Gastroenterol. 2001. PMID: 11819834 Free PMC article. No abstract available.

10

Hepatitis B virus X antigen (HBxAg) and cell cycle control in chronic infection and hepatocarcinogenesis.

Feitelson MA, Reis HM, Liu J, Lian Z, Pan J. Feitelson MA, et al. Front Biosci. 2005 May 1;10:1558-72. doi: 10.2741/1640. Front Biosci. 2005. PMID: 15769646 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

124 results

Search Page

Filters